Oxford Biomedica Solutions
Patrick K. Bamany is a seasoned financial professional with a diverse background in cost accounting and financial analysis. Currently serving as the Cost Accounting Manager at Oxford Biomedica since June 2022, Patrick previously held the position of Plant Controller at Stonyfield, where responsibilities included operational financial management. Other roles include Financial Analyst positions at Faegre Baker Daniels LLP and Johnson Brothers Liquor Co. Patrick also gained experience as an Analytics Analyst at Buffalo Wild Wings and as a Regional Financial Analyst at Essilor. Patrick K. Bamany holds a degree in Finance from St. John's University, The Peter J. Tobin College of Business, earned between 2004 and 2008.
This person is not in any teams
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.